Suchergebnisse - (Standardsuche:Subject:"angiotensin II "type1" receptor blockers")

PubPharm (11)

1

Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease

enthalten in: Journal of human hypertension | 2012

von Pisoni, R. | Acelajado, M. | Cartmill, F. | +5

2

Effects of protein coding polymorphisms in the kallikrein 1 gene on baseline blood pressure and antihypertensive response to irbesartan in Chinese hypertensive patients

enthalten in: Journal of human hypertension | 2011

von Jiang, S. | Hsu, Y. | Venners, S. | +4

3

A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome

enthalten in: Journal of human hypertension | 2010

von Racine, N. | Hamet, P. | Sampalis, J. | +2

4

Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours : a pooled analysis of the PRISMA I and II randomized trials

enthalten in: Journal of human hypertension | 2009

von Williams, B. | Lacourcière, Y. | Schumacher, H. | +2

5

Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system

enthalten in: Journal of human hypertension | 2009

von de la Sierra, A.

6

Cardiac repolarization and its relation to ventricular geometry and rate in reverse remodelling during antihypertensive therapy with irbesartan or atenolol : results from the SILVHIA study

enthalten in: Journal of human hypertension | 2007

von Malmqvist, K. | Kahan, T. | Edner, M. | +1

7

Meta-analysis of large outcome trials of angiotensin receptor blockers in hypertension

enthalten in: Journal of human hypertension | 2006

von Cheung, B. | Cheung, G. | Lauder, I. | +2

CommentIn: Evid Based Cardiovasc Med. 2006 Jun;10(2):89-93. - PMID 16753502

8

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension

enthalten in: Journal of human hypertension | 2005

von Andreadis, E. | Tsourous, G. | Marakomichelakis, G. | +4

9

Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes : clinical effectiveness or clinical discretion?

enthalten in: Journal of human hypertension | 2005

von Gulliford, M. | Charlton, J. | Latinovic, R.

10

Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke

enthalten in: Journal of human hypertension | 2004

von Moriwaki, H. | Uno, H. | Nagakane, Y. | +3

CommentIn: J Hum Hypertens. 2004 Oct;18(10):685-6. - PMID 15129231